Ginkgo Bioworks is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications. Ginkgo Bioworks is an analytics company that designs microorganisms for customers in a range of industries. It is the self-proclaimed "Organism Company" and was … WebApr 9, 2024 · Joel Isaacson & Co. LLC bought a new stake in shares of Ginkgo Bioworks Holdings, Inc. ( NYSE:DNA - Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 115,816 shares of the company's stock, valued at approximately $196,000.
Investor Relations - Ginkgo Bioworks
WebApr 11, 2024 · Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture ... WebSep 2, 2024 · In May 2024, Ginkgo announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), which, if completed, will result in Ginkgo, through a parent entity, Ginkgo Bioworks ... dr gregory ball twin falls id
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Insider …
WebMar 13, 2024 · In This Article. Ginkgo Bioworks Holdings Inc. has $74 million in the recently failed Silicon Valley Bank, all of it inherited from an acquisition it spent $300 million on last year. The Boston ... Web11 votes, 11 comments. 1.1K subscribers in the ginkgobioworks community. Subreddit for news & discussion of Ginkgo Bioworks — the organism company… WebApr 8, 2024 · Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Rating) insider Reshma P. Shetty sold 37,650 shares of the stock in a transaction on Wednesday, April 5th. The … dr. gregory balturshot columbus ohio